Litigation Details for LIQUIDIA TECHNOLOGIES, INC. v. UNITED STATES FOOD AND DRUG ADMINISTRATION (D.D.C. 2024)
✉ Email this page to a colleague
LIQUIDIA TECHNOLOGIES, INC. v. UNITED STATES FOOD AND DRUG ADMINISTRATION (D.D.C. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-08-21 |
| Court | District Court, District of Columbia | Date Terminated | |
| Cause | 05:0706 Judicial Review of Agency Actions | Assigned To | Timothy James Kelly |
| Jury Demand | None | Referred To | |
| Patents | 8,497,393; 9,339,507; 9,358,240; 9,593,066; 9,604,901 | ||
| Link to Docket | External link to docket | ||
Details for LIQUIDIA TECHNOLOGIES, INC. v. UNITED STATES FOOD AND DRUG ADMINISTRATION (D.D.C. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-09-16 | 30 | Answer to Complaint AND Crossclaim | 9,358,240 (“the ’240 patent”), 8,497,393 (“the ’393 patent”), 9,593,066 (“the ’066 patent”), and 9,604,901 …066 patent, the ’901 patent, the ’793 patent, and U.S. Patent No. 10,376,525 (“the ’525 patent”). See United…following patent information: Patent Data Patent No. …Orange Book patents for TYVASO—specifically, U.S. Patent Nos. 9,339,507 (“the ’507 patent”), 9,358,240…to FDA regarding U.S. Patent No. 10,716,793 (“the ’793 patent”). The ’793 patent was timely submitted | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
